欧洲HIV阳性供者向HIV阳性受者实体器官移植现状:西班牙视角
该研究通过2018至2019年西班牙全国调查评估移植团队对HIV D+/R+肾移植和肝移植的态度,并梳理欧洲立法与已发表病例。多数受访专家支持使用病毒学抑制的HIV D+器官,但欧洲仅少数国家合法允许,已发表10例移植1年结局良好。
要点
- 西班牙66%受访专家支持对HIV R+使用病毒学抑制的HIV D+器官。
- 欧洲仅6国允许HIV D+器官移植,11国禁止,18国未监管。
- 已发表10例HIV D+/R+移植(6肾4肝),1年结局良好。
核心结论
- 受访西班牙专家支持对HIV R+使用病毒学抑制的HIV D+器官进行移植。
- 该操作在欧洲仅极少数国家合法允许,结果应推动欧洲供者法律改革。
研究设计与样本
- 2018年和2019年分别对西班牙24个肝移植中心和39个肾移植中心进行两次全国性问卷调查。
- 由HIV/感染病、肾内科/肝内科、泌尿外科/肝外科及移植协调专家填写问卷,按专业分析应答。
- 咨询欧洲代表了解各国HIV D+/R+法律框架,并对2000至2025年已发表病例进行叙述性综述。
主要发现
- 西班牙调查中所有肝移植和肾移植团队至少一名成员应答(63/63,100%)。
- 252名受访专家中167名(66%)支持对HIV R+使用病毒学抑制且接受抗逆转录病毒治疗的HIV D+器官,不支持使用非病毒学抑制的HIV D+器官。
- 所有受访者支持实施专用知情同意书,多数表示愿意参与HIV D+/R+试验,肝移植与肾移植团队间无 major 差异。
- 欧洲层面,HIV D+器官使用在6国(17%)允许、11国(31.5%)禁止、18国(51.5%)未监管。
- 已发表10例HIV D+/R+移植(6例肾、4例肝),1年结局良好。
关键数值与推荐
- 西班牙受访专家支持使用病毒学抑制的HIV D+器官,不支持非病毒学抑制的HIV D+器官。
- 所有受访者支持实施专用知情同意书。
- 欧洲允许、禁止和未监管HIV D+器官使用的国家分别为6个(17%)、11个(31.5%)和18个(51.5%)。
临床怎么用
- 在合法允许的地区,可考虑对HIV R+使用病毒学抑制的HIV D+器官,并配套专用知情同意。
- 临床团队可参考已发表10例移植的1年良好结局,但需结合当地法律与监管框架。
- 推动欧洲供者法律改革以扩大HIV D+/R+移植可及性。
局限性
- 西班牙数据基于问卷调查的专家态度,非实际移植结局。
- 欧洲立法信息来自代表性咨询,已发表病例仅10例,证据有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: There is limited information on the use of organs from HIV-positive donors (HIV D+) for HIV-positive recipients (HIV R+) in Europe. In some countries, the use of HIV D+ organs is prohibited by law. This study aimed to assess the attitudes of Spanish kidney transplant (KT) and liver transplant (LT) teams towards HIV D+/R + KT/LT through a nationwide survey, and to evaluate the current situation across Europe regarding legislation and reported cases. METHODS: In 2018 and 2019, 2 surveys were conducted across Spain's 24 LT and 39 KT centres, respectively. Specialists in HIV/infectious diseases, nephrology/hepatology, urology/liver surgery and transplant coordination completed a questionnaire, with responses analysed by speciality. We also consulted European representatives on national legal frameworks regarding HIV D+/R+ and conducted a narrative review of published cases (2000-2025). RESULTS: The Spanish survey was answered by at least one member of all Spanish LT and KT teams (63/63, 100%). Most specialists who responded to the survey (167/252; 66%) supported using organs from virologically suppressed (VS) HIV D+ on antiretroviral therapy, high-risk and serodiscordant couples, but not from non-VS HIV D+, for HIV R+. All respondents endorsed implementing a dedicated consent form, and a majority expressed willingness to participate in an HIV D+/R+ trial. No major differences were observed between the LT and KT teams. At the European level, the use of organs from HIV D+ was permitted, prohibited or unregulated in 6 (17%), 11 (31.5%) and 18 (51.5%) countries, respectively. Ten HIV D+/R+ transplants (6 kidneys and 4 livers) have been published, with good 1-year outcomes. DISCUSSION: The surveyed Spanish specialists would agree on using organs from VS HIV D+ for HIV D+/R+ transplants. This procedure is only legally allowed in very few European countries. These results should promote changes in donor laws across Europe.
引用
- Miro JM, Amondarain NL, Serrano L, et al. Current situation of solid organ transplantation from HIV-positive donors to HIV-positive recipients in Europe: the Spanish perspective. Clin Microbiol Infect. 2025. PMID: 40907699. doi:10.1016/j.cmi.2025.08.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。